Lenalidomide in 5q minus myelodysplastic syndrome: how long is enough?

Ann Hematol. 2010 Jan;89(1):105-6. doi: 10.1007/s00277-009-0775-x. Epub 2009 Jun 27.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Female
  • Follow-Up Studies
  • Gene Deletion*
  • Humans
  • Lenalidomide
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / genetics*
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use

Substances

  • Thalidomide
  • Lenalidomide